VivoSim Labs (VIVS) EBT Margin Growth (5y) (2016 - 2024)
VivoSim Labs (VIVS) EBT Margin Growth (5y) (2016 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1.32 Mn |
| Sep 30, 2024 | -848,407.00 |
| Jun 30, 2024 | -707,098.00 |
| Mar 31, 2024 | -870,412.00 |
| Dec 31, 2023 | -3.98 Mn |
| Jun 30, 2023 | -435,660.00 |
| Mar 31, 2023 | -392,802.00 |
| Dec 31, 2022 | -175,629.00 |
| Sep 30, 2022 | -368,227.00 |
| Mar 31, 2022 | 116,754.00 |
| Dec 31, 2019 | 1.47 Mn |
| Sep 30, 2019 | 1.01 Mn |
| Jun 30, 2019 | 2.81 Mn |
| Sep 30, 2018 | -1.79 Mn |
| Jun 30, 2018 | 815,292.00 |
| Dec 31, 2017 | 154,505.00 |
| Sep 30, 2017 | 454,041.00 |
| Jun 30, 2017 | -77,059.00 |
| Dec 31, 2016 | 267,701.00 |
| Sep 30, 2016 | -121,671.00 |